Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

A TB patient takes his daily TB medication at MSF's Insein clinic, Yangon, Myanmar, Feb. 22, 2018. Photograph by Alessandro Penso
Press release
Press release |
21 March 2018
Tuberculosis

Governments still not doing enough to scale up access to newer TB drugs

2 min
A member of the MSF vaccination team provides a single dose of oral cholera vaccine to a boy at True Vine Church, one of the 15 sites used by MSF in the district of Kanyama during a massive vaccination campaign in Lusaka Photograph by Laurence Hoenig/MSF
Press release
Press release |
06 March 2018
Vaccines
Zambia

Zambia: Encouraging new results further demonstrate effectiveness of the single dose oral cholera vaccine

3 min
Child receiving vaccination in MSF clinic Photograph by Julia Kourafa
Press release
Press release |
06 March 2018
Vaccines
Greece

Greece: Around 1,000 migrant and refugee children vaccinated by MSF in Lesvos

MDR-TB Patient shows daily drug dosis Photograph by Bithin Das
Press release
Press release |
06 March 2018
Research and development

MSF welcomes Members of the European Parliament response to the US pharmaceutical pressure to stop EU action on high drug prices

Vials of PCV13, a vaccine that protects children against pneumonia and meningitis. At 9 Euros a dose (three doses are necessary for the vaccine to be effective) PCV13 is currently priced at a rate much higher than most people in Central African Republic can afford. Photograph by Sandra Smiley Photograph by Sandra Smiley
Press release
Press release |
06 February 2018
Intellectual property and trade Vaccines
Republic of Korea

MSF challenges Pfizer’s monopoly on lifesaving pneumonia vaccine in Korea

4 min
Photograph by Siddharth Singh Photograph by Siddharth Singh

IP RCEP protest in India.

Press release
Press release |
18 December 2017
Hepatitis C
China

MSF challenges Gilead’s patent application for hepatitis C combination treatment in China, to bring down prices

MSF172231 Photograph by Alexis Huguet/Hans Lucas
Press release
Press release |
04 December 2017
HIV/AIDS

Delivering differently to reach people living with HIV in West and Central Africa

6 min
Mark Walsh, head of mission for MSF in Ukraine officially opening MSF’s project with Ivan Dudla, medical specialist from the regional health authorities in Mykolaiv. Photograph by MSF
Press release
Press release |
01 December 2017
Hepatitis C
Ukraine

Ukraine: People co-infected with HIV to receive hepatitis C treatment in Mykolaiv region

5 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury